Related references
Note: Only part of the references are listed.Evaluation of the Finnish Diabetes Risk Score as a screening tool for undiagnosed type 2 diabetes and dysglycaemia among early middle-aged adults in a large-scale European cohort. The Feel4Diabetes-study
Christina Mavrogianni et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Validity of the FINDRISC as a prediction tool for diabetes in a contemporary Norwegian population: a 10-year follow-up of the HUNT study
Anne Jolle et al.
BMJ OPEN DIABETES RESEARCH & CARE (2019)
Diagnostic accuracy of the Finnish Diabetes Risk Chock for Score (FINDRISC) for undiagnosed T2DM in Peruvian population
Antonio Bernabe-Ortiz et al.
PRIMARY CARE DIABETES (2018)
Change in lifestyle behaviors and diabetes risk: evidence from a population-based cohort study with 10 year follow-up
Adina L. Feldman et al.
INTERNATIONAL JOURNAL OF BEHAVIORAL NUTRITION AND PHYSICAL ACTIVITY (2017)
Evaluating FINDRISC as a screening tool for type 2 diabetes among overweight adults in the PREVIEW:NZ cohort
Marta Paulino Silvestre et al.
PRIMARY CARE DIABETES (2017)
Evaluation of the modified FINDRISC to identify individuals at high risk for diabetes among middle-aged white and black ARIC study participants
Manjusha Kulkarni et al.
DIABETES OBESITY & METABOLISM (2017)
Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis
Yunwei Li et al.
ATHEROSCLEROSIS (2017)
Finnish Diabetes Risk Score Is Associated with Impaired Insulin Secretion and Insulin Sensitivity, Drug-Treated Hypertension and Cardiovascular Disease: A Follow-Up Study of the METSIM Cohort
Maria Fizelova et al.
PLOS ONE (2016)
Development and Validation of a Risk-Score Model for Type 2 Diabetes: A Cohort Study of a Rural Adult Chinese Population
Ming Zhang et al.
PLOS ONE (2016)
Adapting existing diabetes risk scores for an Asian population: a risk score for detecting undiagnosed diabetes in the Mongolian population
Otgontuya Dugee et al.
BMC PUBLIC HEALTH (2015)
Early Detection and Treatment of Type 2 Diabetes Reduce Cardiovascular Morbidity and Mortality: A Simulation of the Results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe)
William H. Herman et al.
DIABETES CARE (2015)
Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people
Anoop Dinesh Shah et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
Calculated and perceived cardiovascular risk in asymptomatic subjects submitted to a routine medical evaluation: The perception gap
Marcelo Katz et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2015)
Global estimates of undiagnosed diabetes in adults
Jessica Beagley et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2014)
Screening for people with glucose metabolism disorders within the framework of the DEMOJUAN project (DEMOnstration area for primary prevention of type 2 diabetes, JUAN Mina and Barranquilla, Colombia)
Noël C. Barengo et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2013)
Recommendations on screening for type 2 diabetes in adults
Kevin Pottie et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2012)
C-reactive protein concentration predicts mortality in type 2 diabetes: the Diabetes Heart Study
A. J. Cox et al.
DIABETIC MEDICINE (2012)
The Finnish Diabetes Risk Score (FINDRISC) as a screening tool for hepatic steatosis
Jose A. M. Carvalho et al.
ANNALS OF MEDICINE (2011)
Hepatic Steatosis, Obesity, and the Metabolic Syndrome Are Independently and Additively Associated With Increased Systemic Inflammation
Chiadi E. Ndumele et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Does microvascular disease predict macrovascular events in type 2 diabetes?
R. S. Rosenson et al.
ATHEROSCLEROSIS (2011)
Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece
K. Makrilakis et al.
DIABETES & METABOLISM (2011)
Prevalence of Diabetes and High Risk for Diabetes Using A1C Criteria in the US Population in 1988-2006
Catherine C. Cowie et al.
DIABETES CARE (2010)
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
Stephen Kaptoge et al.
LANCET (2010)
The role of inflammation on atherosclerosis, intermediate and clinical cardiovascular endpoints in type 2 diabetes mellitus
A. Ray et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2009)
The Finnish Diabetes Risk Score Is Associated with Insulin Resistance and Progression towards Type 2 Diabetes
Peter E. H. Schwarz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
The validity of the Finnish Diabetes Risk Score for the prediction of the incidence of coronary heart disease and stroke, and total mortality
Kam Sliventoinen et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2005)
International physical activity questionnaire:: 12-country reliability and validity
CL Craig et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2003)
The diabetes risk score -: A practical tool to predict type 2 diabetes risk
J Lindström et al.
DIABETES CARE (2003)
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus
AD Pradhan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
High-sensitivity C-reactive protein - Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease
PM Ridker
CIRCULATION (2001)
Share Paper
